London, 18 July 2022 – Hikma Pharmaceuticals PLC (Hikma, Group), will announce its interim financial results for the six months ended 30 June 2022 on Thursday 4 August 2022.
18 July 2022
Reporting, Corporate, Press Release
A recording of the presentation will be available on the Group’s website at www.hikma.com from 7:00am BST. Hikma will also hold a live Q&A conference call for analysts at 10:30am BST, and a recording will be made available on the Company’s website.
To join via conference call please dial:
United Kingdom toll-free: +44 800 640 6441
United Kingdom toll/international: +44 20 3936 2999
Access code: 155618
For further information please contact Tiina Lugmayer – firstname.lastname@example.org.